AstraZeneca Announces Licensing Agreement with China Medical System Holdings for commercialization Rights in China to Plendil; CMS to pay AstraZeneca $310M for License to Sell Plendil in China
February 29, 2016 at 04:27 AM EST
AstraZeneca (NYSE: AZN) today announced it has entered into a licensing agreement with China Medical System Holdings Ltd (CMS) for the ...
